Frost & Sullivan: Momentum Mounting for Catheter Ablation Technologies in Treatment of Atrial Fi... ( Clinical Specialists Provide Feedback...)

Frost & Sullivan: Momentum Mounting for Catheter Ablation Technologies in Treatment of Atrial Fibrillation

Date:6/8/2009

Clinical Specialists Provide Feedback on Current and Future Trends

MOUNTAIN VIEW, Calif., June 8 /PRNewswire/ -- A recent Frost & Sullivan end-user survey shows increased awareness and utilization of new tools and approaches to treating atrial fibrillation (Afib). Of the various forms of cardiac arrhythmia, AFib is the one of the most prevalent and hardest to treat. Two and a half million people in the U.S. have AFib, and about one million are symptomatic and do not respond well to traditional drug therapy and behavior modification (diet, exercise). Approximately 200,000 new cases of AFib are diagnosed annually in the U.S. While medical device therapy options are increasing, their adoption and utilization for atrial fibrillation has been slow.

(Logo: http://www.newscom.com/cgi-bin/prnh/20081117/FSLOGO)

Market estimates show that less than 20 percent of the addressable market for atrial fibrillation therapy is being served due to limited regulatory approval and lack of provider training and expertise. The market that participants like to call "two years away, for the past ten years," is now building momentum due to ongoing clinical research and recent FDA approval of the first catheter ablation system for treatment of atrial fibrillation in February of 2009.

The latest end-user study from Frost & Sullivan's Medical Device group assesses a variety of critical dynamics of catheter ablation approaches and technologies in treatment of both paroxysmal and long-standing persistent atrial fibrillation. Electrophysiologists, cardiologists, and cardiac surgeons provided insight on factors such as adoption drivers, clinical preferences, expected impact of the economy, referral patterns, assistive technologies and brand perceptions.

Select findings include the following:

0

GOOD

Page: 1 2 3
Related medicine news :

1. Frost & Sullivan Presents LG Electronics IRIS With the 2009 Global Iris Recognition Biometrics Market Customer Value Leadership of the Year Award
2. IT Budgets of Healthcare Organizations in Asia Pacific Region Expected to Grow, Regardless of the Economic Slowdown, says Frost & Sullivan
3. Advanced Technologies Pump Growth Into European Cardiac Rhythm Management Market, Affirms Frost & Sullivan
4. European Prebiotics Market Diversifies Strongly Across New Application Sectors in Food and Beverage Industry, Finds Frost & Sullivan
5. Frost & Sullivan: Healthcare Delivery in APAC Upon Economic Recession
6. Frost & Sullivan Looks at the Influence of Chinas New Health Reform on the Pharmaceutical Market
7. Frost & Sullivan: SMBG Within Asia Pacific
8. Transatlantic Regulatory Integration of Drug Approval Process Vital for the Global Pharmaceutical Industry, Notes Frost & Sullivan
9. Frost & Sullivan: Clinical and Cost Benefits to Promote Uptake of Advanced Wound Management Technologies Across Europe
10. Frost & Sullivan Cites Gearworks for Creativity and Customer Service in the Home Healthcare Market
11. Focus on Rapid Medical Response to Improve the Quality of Healthcare and Drive the Ambulance Services Market in Europe, According to Frost & Sullivan

Post Your Comments:

Frost & Sullivan: Momentum Mounting for Catheter Ablation Technologies in Treatment of Atrial Fi...( Clinical Specialists Provide Feedback...),Health